2018 Annual Meeting | C178 - Neuro-oncology in 2018: Navigating Current Trends

Date Thursday 04/26/18

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Maciej M. Mrugala, MD, PhD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be able to identify novel developments in the field of neuro-oncology with emphasis on molecular testing, and new emerging therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Advanced Practice Provider

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:05 AM	Luncheon	Introduction Maciej M. Mrugala, MD, PhD, MPH, FAAN
07:05 AM - 07:45 AM	Speaker	Novel Medical Therapies in Neuro-oncology Maciej M. Mrugala, MD, PhD, MPH, FAAN
07:45 AM - 08:20 AM	Speaker	Advances in Surgical Treatment of Brain Tumors Bernard Bendok, MD
08:20 AM - 09:00 AM	Speaker	Deciphering Molecular Testing in Neuro-oncology Seema Nagpal, MD, FAAN

Faculty Disclosures
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Seema Nagpal, MD, FAAN	Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mirati. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Midatech.
Bernard Bendok, MD	No disclosure on file

��ɫ��

��ɫ��